AI-generated videos are flooding social media amid the war in Iran, distorting what viewers see online. Here’s how to tell what’s real and what’s fake.

After years of struggling with ADHD symptoms, Samantha was encouraged by an advertisement she saw on TikTok for dopamine patches. Samantha, who is using her first name to protect her privacy, has ...

Donald Trump was allegedly Jeffrey Epstein’s “best friend” for roughly 15 years, and the president’s name shows up countless ...

Accounts are drawing millions of views for pro-Tehran posts by tapping into the conspiracy theory that the president attacked Iran to distract the public from the Epstein files.

Insulet Stock: why GLP-1 fears are overblown, with growth driven by Europe/MENA expansion. Read here for a detailed analysis on PODD stock.

Michael Pratt was sentenced to 27 years in federal prison after pleading guilty to one count of sex trafficking by force, fraud or coercion and one count of conspiracy to commit the same crime.

Insulin delivery company Insulet Corporation (NASDAQ:PODD) will be reporting earnings this Wednesday morning. Here’s what to look for. Insulet beat analysts’ revenue expectations by 3.9% last quarter, ...

Insulet Corporation (NASDAQ:PODD) designs, manufactures, and sells insulin delivery systems for people with diabetes. Its flagship product is the Omnipod Insulin Management System, a tubeless, ...

We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD. Insulet Corporation’s share was trading at ...

Short-form videos have become one of the dominant ways young people engage with social media. These are clips lasting seconds up to a few minutes, driven by personalized algorithms that are deeply ...

Fintel reports that on January 12, 2026, Barclays downgraded their outlook for Insulet (NasdaqGS:PODD) from Equal-Weight to Underweight. Analyst Price Forecast Suggests 33.30% Upside As of December 21 ...

Fintel reports that on November 19, 2025, UBS upgraded their outlook for Insulet (NasdaqGS:PODD) from Neutral to Buy. Analyst Price Forecast Suggests 9.42% Upside As of November 17, 2025, the average ...